Private Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.7M | Sell |
53,593
-12,267
| -19% | -$847K | 0.29% | 52 |
|
|
2025
Q1 | $4.57M | Buy |
65,860
+16,560
| +34% | +$1.15M | 0.38% | 46 |
|
|
2024
Q4 | $4.24M | Buy |
49,300
+16,097
| +48% | +$1.38M | 0.32% | 48 |
|
|
2024
Q3 | $3.95M | Buy |
33,203
+20,188
| +155% | +$2.4M | 0.32% | 51 |
|
|
2024
Q2 | $1.86M | Buy |
13,015
+5,445
| +72% | +$777K | 0.14% | 66 |
|
|
2024
Q1 | $972K | Buy |
7,570
+1,620
| +27% | +$208K | 0.08% | 86 |
|
|
2023
Q4 | $616K | Buy |
+5,950
| New | +$616K | 0.05% | 101 |
|
|
2017
Q1 | – | Sell |
-22,800
| Closed | -$409K | – | 115 |
|
|
2016
Q4 | $409K | Sell |
22,800
-3,000
| -12% | -$53.8K | 0.1% | 85 |
|
|
2016
Q3 | $537K | Sell |
25,800
-6,200
| -19% | -$129K | 0.13% | 79 |
|
|
2016
Q2 | $860K | Buy |
32,000
+6,200
| +24% | +$167K | 0.21% | 71 |
|
|
2016
Q1 | $699K | Hold |
25,800
| – | – | 0.17% | 79 |
|
|
2015
Q4 | $749K | Buy |
25,800
+5,000
| +24% | +$145K | 0.18% | 85 |
|
|
2015
Q3 | $564K | Sell |
20,800
-800
| -4% | -$21.7K | 0.14% | 97 |
|
|
2015
Q2 | $591K | Buy |
21,600
+6,000
| +38% | +$164K | 0.13% | 99 |
|
|
2015
Q1 | $416K | Sell |
15,600
-6,000
| -28% | -$160K | 0.1% | 114 |
|
|
2014
Q4 | $457K | Sell |
21,600
-6,600
| -23% | -$140K | 0.11% | 113 |
|
|
2014
Q3 | $671K | Hold |
28,200
| – | – | 0.15% | 112 |
|
|
2014
Q2 | $651K | Buy |
28,200
+200
| +0.7% | +$4.62K | 0.14% | 110 |
|
|
2014
Q1 | $639K | Hold |
28,000
| – | – | 0.15% | 106 |
|
|
2013
Q4 | $517K | Hold |
28,000
| – | – | 0.12% | 121 |
|
|
2013
Q3 | $474K | Hold |
28,000
| – | – | 0.11% | 125 |
|
|
2013
Q2 | $434K | Buy |
+28,000
| New | +$434K | 0.11% | 121 |
|